Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The NIHR Research and Innovation for Global Health Transformation (RIGHT) programme has awarded £4.9 million to help fund a project investigating epilepsy in sub-Saharan Africa.

EEG being used with child with epilepsy in Kenya
EEG being used with child with epilepsy in Kenya

Professor Charles Newton, Department of Psychiatry, and Professor Arjune Sen, Nuffield Department of Clinical Neurosciences, University of Oxford, together with colleagues at University College London and Newcastle University will work with colleagues in Ghana, Kenya and Tanzania, conducting a series of studies designed to help experts better understand the history of epilepsy, investigate why people with epilepsy are so disadvantaged, and then set out to improve the situation.

The project will include:

  • Preventing epilepsy in southern Tanzania
  • Developing an app to help healthcare workers to better diagnose epilepsy, especially non-convulsive epilepsy, allowing earlier treatment
  • Determining if text messaging can increase the number of people who take their medication correctly
  • Training primary health care staff in the care of people with epilepsy
  • Developing students and other people to lead future projects in epilepsy.


This project could dramatically change the lives of people with epilepsy in sub-Saharan Africa. The results of our research will be shared with international organisations, such as, the International League Against Epilepsy and the World Health Organisation.
Professor Charles Newton, Department of Psychiatry, University of Oxford.


The NIHR has invested £34 million of funding into global health research projects to tackle epilepsy, infection-related cancers and severe stigmatising skin diseases in low- and middle-income countries (LMICs). These three topic areas were selected because they are key areas of unmet need where a relatively small investment can result in a transformative impact.

The NIHR Research and Innovation for Global Health Transformation (RIGHT) programme has awarded Official Development Assistance (ODA) funding to eight projects led by teams made up of researchers in the UK and those in LMICs.


NIHR invests £34million into global health research article.


Please follow the link below to read the news on the NIHR BRC website.